Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1698 USD | -4.61% | +2.72% | -32.00% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Apr. 01 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Financials (USD)
Sales 2024 * | 9.99M | Sales 2025 * | 11.99M | Capitalization | 3.98M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.47
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on ReShape Lifesciences Inc.
1 day | -4.61% | ||
1 week | +2.72% | ||
Current month | -7.92% | ||
1 month | -6.70% | ||
3 months | -17.53% | ||
6 months | -23.55% | ||
Current year | -32.00% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 20-01-31 |
Director of Finance/CFO | 63 | 21-06-14 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 15-12-31 |
Dan Gladney
CHM | Chairman | 70 | 15-10-31 |
Director/Board Member | 70 | 21-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.1698 | -4.61% | 318,579 |
24-04-25 | 0.178 | +5.89% | 176,187 |
24-04-24 | 0.1681 | -1.41% | 117,465 |
24-04-23 | 0.1705 | +2.16% | 180,674 |
24-04-22 | 0.1669 | +0.97% | 103,794 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.00% | 3.98M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- RSLS Stock